ZYBERNO
Stock Report
Updated Sep 1, 2026

METAVIA INC. (MTVA)

Healthcare • NASDAQ

$1.70

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
14.0/100
POOR BUSINESS
METAVIA INC. (MTVA) scores 14/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-209.7%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.04x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-1,758.0%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

METAVIA INC. (MTVA) stock report — Zyberno Score 14/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, MTVA generated -$16.32M in Owner Earnings. Reinvestment rate: 0.2%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:1.70
Market Cap:$10.08M

Valuation Multiples (2)

P/B Ratio:1.48x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:-$549.81K

Price Action & Momentum (1)

% of 52-Week High:8.9%
B. Profitability Assessment

Return Metrics (5)

ROA:-107.9%
Reinvestment Rate:0.2%
Fundamental Growth Rate (g):-2.7%

Margin Analysis (1)

Ebitda Margin:0.0%

Yield Metrics (2)

Earnings Yield:-$565.10
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-47.7%
Latest Earnings Filed:2026-08-06
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:2.06x
Quick Ratio:2.06x
Cash Ratio:1.99x

Leverage Analysis (3)

Debt To Equity Ttm:0.04x
Debt-to-Equity Ratio:0.04x
Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-34.79x
Times Interest Earned:-34.79

Capital Structure (4)

Working Capital:6,721,000.00
Cash And Cash Equivalents:12,634,000.00
Long Term Debt:$103.00K
Net Debt:-$10.63M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$0.00
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$0.00-$14.93M

Bottom Line Performance (3)

-$14.45M
Income Before Tax:-$14.45M
Ebitda Ttm:-14,912,000.00

Operating Expenses (5)

Operating Expenses:14,931,000.00
R And D Expense:7,734,000.00
Sga Expense:7,197,000.00
Income Tax Expense:$0.00
Interest Expense:394,000.00

Expense Ratios (1)

Ebitda Margin:0.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$13.27M
Current Assets:$13.07M
Ppe Net:90,000.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:6,449,000.00
Current Liabilities:6,346,000.00
Long Term Debt:$103.00K
Short Term Debt:$1.90M

Equity & Capital (3)

Equity:$6.82M
Retained Earnings:-$157.97M
Common Stock:100,000,000.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:0.00
Accounts Payable:921,000.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:130,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$15.14M-$16.32M

Investment Activities (1)

Investing Cash Flow:$0.00

Financing Activities (3)

Financing Cash Flow:$7.71M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:19,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-8.42
-$8.42
Earnings Per Share Ttm:-$2.44

Revenue & Cash Per Share (1)

Operating Cash Flow Per Share:-$2.65

Book Value & Capital (2)

Book Value Per Share:$1.15
Cash Per Share:2.13

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (1)

Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:-999.00
Cash Conversion Cycle:-999.00
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:30.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$16.32M

Damodaran Growth Analysis (2)

Reinvestment Rate:0.2%
Fundamental Growth Rate (g):-2.7%
B. Log-Linear Regression Growth Analysis

Other Growth Rates (1)

Book Value Growth Rate (Linear):-15.7%
C. Company Profile & Context

Corporate Information (6)

Symbol:MTVA
Company Name:METAVIA INC.
Sector:Healthcare
Industry:Pharmaceuticals
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:5.93M
Shares Outstanding Basic:5.93M
Shares Outstanding Diluted:5.93M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 15:46:32 UTC
Data Timestamp:2026-08-21T17:19:21.874749
Scroll to Top